Kuvatris Therapeutics, Inc.
PXMDDelisted Aug 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811623
Kuvatris Therapeutics, Inc. was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Mar 14, 2024; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Kuvatris Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −2 vs. Q1 2023
- Shares held
- 210.9K
- +49.8K (+30.9%) vs. Q1 2023
- Total value
- $165.3K
- −$142.2K (−46.2%) vs. Q1 2023
- New holders
- 2
- 2 more added
- Sold out
- 4
- 1 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PXMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 1 | $12 |
| Q1 2024 | 8 | $64.7K |
| Q4 2023 | 9 | $84.2K |
| Q3 2023 | 13 | $85.8K |
| Q2 2023 | 8 | $165.3K |
| Q1 2023 | 10 | $307.6K |
| Q4 2022 | 8 | $176.0K |
| Q3 2022 | 6 | $155.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Kuvatris Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 68,991 | $54.2K | 0.00% | +68,991 | New |
| Vanguard Group Inc | 54,959 | $43.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 30,781 | $24.2K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 25,982 | $20.0K | 0.00% | +25,982 | New |
| State Street Corp | 21,900 | $17.2K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,746 | $6.09K | 0.00% | +3,730+92.9% | Added |
| Bank of America Corp | 500 | $393 | 0.00% | −3,710−88.1% | Reduced |
| Wells Fargo & Company | 35 | $28 | 0.00% | +12+52.2% | Added |
| UBS Group AG | 0 | $0 | 0.00% | −17,735−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,678−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,827−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |